Expression of soluble endothelial adhesion molecules in clinical cardiopulmonary bypass

Perfusion (United Kingdom) - Tập 13 Số 5 - Trang 314-321 - 1998
Joseph Galea1, Naomi Rebuck2, Adam Finn2, A. Manché3, Neil Moat4
1Cardiac Sciences Section, Northern General Hospital, Sheffield
2Department of Child Health, University of Sheffield, Sheffield
3Department of Cardiothoracic Surgery, Northern General Hospital, Sheffield.
4Cardiac Sciences Section, University of Sheffield, Sheffield

Tóm tắt

Soluble endothelial adhesion molecule expression in clinical cardiopulmonary bypass (CPB) was investigated. Neutrophil-mediated endothelial injury plays an important role in CPB-induced organ dysfunction. The adhesion of neutrophil to the endothelium is central to this process. It has been well documented that CPB induces neutrophil activation and changes in neutrophil adhesion molecule expression, but the effect of CPB on endothelial cell activation is not known. This study was designed to measure soluble endothelial adhesion molecules during CPB.

We made serial measurements (by specific enzyme-linked immunoabsorbent assay) of plasma levels of the soluble endothelial adhesion molecules, ICAM-1 and E-selectin in patients undergoing routine CPB ( n =7) and in a control group (thoracotomy, n = 3).

The results show an initial significant decrease during CPB followed by an increase in plasma E-selectin from 29.3 ± 5.1 ng/ml (mean ± SEM) prebypass to 34.0 ± 5.4 ng/ml at 48 h postbypass. Likewise, plasma ICAM-1 significantly decreased during CPB and then increased from 246.3 ± 38.0 ng/ml before bypass to 324.8 ± 25.0 ng/ml and 355.0 ± 23.0 ng/ml at 24 and 48 h after bypass, respectively. The rise in levels is statistically significant ( p < 0.05).

This study shows a decrease in circulating ICAM-1 and soluble E-selectin during CPB and an increase in their levels at 48 h after CPB.

Từ khóa


Tài liệu tham khảo

10.1016/0003-4975(94)90380-8

10.1016/S0003-4975(10)60006-9

10.1016/S0022-5223(19)41169-0

10.1016/S0008-6363(96)00172-1

Westaby S., 1987, Crit Rev Biocomp, 3, 193

10.1016/0003-4975(93)91143-B

10.1016/0003-4975(92)91021-Z

10.1016/0003-4975(92)91446-G

10.1016/0003-4975(93)91007-A

10.1172/JCI114111

10.1159/000414430

10.1016/S0022-5223(19)33966-2

10.1097/00002480-199407000-00059

10.1016/S0022-5223(19)33910-8

10.1161/01.CIR.92.9.334

10.1016/0003-4975(94)90995-4

10.1016/S0003-4975(10)62668-9

Hugli TE., 1979, Current topics in molecular immunology, 25

O’Flaherty JT, 1977, J Immunol, 199, 232, 10.4049/jimmunol.119.1.232

Harlan JM., 1987, Acta Med Scand, 715, 123, 10.1111/j.0954-6820.1987.tb09912.x

10.1016/S1010-7940(96)80152-7

Root RK., 1989, Trans Am Climatol Assoc, 101, 207

10.1055/s-0038-1647029

10.1038/346425a0

10.1016/0092-8674(90)90661-W

10.1126/science.2466335

10.1073/pnas.84.24.9238

10.1084/jem.164.2.661

10.1172/JCI112200

10.1073/pnas.87.5.1673

Patarroyo M, 1989, Scand J Immunol, 30, 129, 10.1111/j.1365-3083.1989.tb01197.x

10.1111/j.1600-065X.1990.tb00562.x

Pober JS, 1986, J Immunol, 136, 1680, 10.4049/jimmunol.136.5.1680

Newman W, 1993, J Immunol, 150, 644, 10.4049/jimmunol.150.2.644

10.1056/NEJM198902093200606

10.1016/0092-8674(90)90230-C

10.1001/archsurg.1988.01400360066010

Rothlein R, 1991, J Immunol, 147, 3788, 10.4049/jimmunol.147.11.3788

10.1016/0003-4975(93)90342-F

Menasché P, 1994, Circulation, 90, 275

Kawalski R, 1997, J Mol Clin Cardiol, 29, A110

10.3109/08820139509062782

Boldt J, 1995, Anaeth Analg, 81, 1129

10.1016/S1053-0770(96)80094-2

Thông tin
Thông tin xuất bản

Perfusion (United Kingdom)

Tập 13 Số 5

314-321

Thông tin tác giả